NVST vs PATH
Envista Holdings Corp (NVST) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
NVST currently screens at market cap $3.72B and trailing P/E 55.8. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the NVST and PATH stock pages for the full models.
Not investment advice.